KZIA
Kazia Therapeutics·NASDAQ
--
--(--)
--
--(--)
KZIA Filings
Filing Date
Form Description
Form Type
2026-01-27
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-27 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-27
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-27 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-27
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-27 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-27
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-27 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-27
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-27 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-23
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026-01-23 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-12-29
Form EFFECT - Notice of Effectiveness
2025-12-29 ·
Form EFFECT - Notice of Effectiveness
2025-12-29
Form EFFECT - Notice of Effectiveness
2025-12-29 ·
Form EFFECT - Notice of Effectiveness
2025-12-23
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-23 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-23
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-23 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
